Most cited papers from Inn-Salzach-Klinikum

Inn-Salzach-Klinikum

What are the most cited papers from Inn-Salzach-Klinikum?

The most cited paper from Inn-Salzach-Klinikum is "The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry" (Pierre Baumann, Christoph Hiemke, Sven Ulrich et al., 2004), with 422 citations. Next come "Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition" (345) and "The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry" (343).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 40 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry Pierre Baumann, Christoph Hiemke, Sven Ulrich et al. · Pharmacopsychiatry	Nov 2004	422
2	Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition Borwin Bandelow et al. · The World Journal of Biological Psychiatry Open access	15 Jul 2016	345
3	The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry I. Gaertner, Pierre Baumann, Christoph Hiemke et al. · Pharmacopsychiatry	25 Jan 2005	343
4	Response and remission criteria in major depression – A validation of current practice Michael J Riedel, Hans‐Jürgen Möller, Michael Obermeier et al. · Journal of Psychiatric Research	6 May 2010	290
5	Prediction of Individual Response to Electroconvulsive Therapy via Machine Learning on Structural Magnetic Resonance Imaging Data Ronny Redlich, Nils Opel, Dominik Grotegerd et al. · JAMA Psychiatry	4 May 2016	279
6	MAO-inhibitors in Parkinson's Disease Peter Franz Riederer, Gerd Laux · Experimental Neurobiology Open access	31 Mar 2011	216
7	Oxytocin Receptor Gene Methylation: Converging Multilevel Evidence for a Role in Social Anxiety Christiane Ziegler, Udo Dannlowski, David Bräuer et al. · Neuropsychopharmacology Open access	7 Jan 2015	195
8	Does early improvement triggered by antidepressants predict response/remission? — Analysis of data from a naturalistic study on a large sample of inpatients with major depression Verena Henkel, Florian Seemüller, Michael Obermeier et al. · Journal of Affective Disorders	23 Nov 2008	167
9	Virtual reality exposure in anxiety disorders: Impact on psychophysiological reactivity Julia Diemer, Andreas Mühlberger, Paul Pauli et al. · The World Journal of Biological Psychiatry	25 Mar 2014	148
10	Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers Iris E. Jansen et al. · Acta Neuropathologica Open access147 authors	6 Sep 2022	147
11	Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders Rebecca Schennach-Wolff, Markus Jäger, Florian Seemüller et al. · Schizophrenia Research	28 Jun 2009	120
12	Fear and physiological arousal during a virtual height challenge—effects in patients with acrophobia and healthy controls Julia Diemer, Nora Lohkamp, Andreas Mühlberger et al. · Journal of Anxiety Disorders	10 Nov 2015	117
13	Boosting Learning Efficacy with Noninvasive Brain Stimulation in Intact and Brain-Damaged Humans Florian Herpich, Michael D. Melnick, Sara Agosta et al. · Journal of Neuroscience Open access	27 May 2019	110
14	Predictors of Relapse in the Year After Hospital Discharge Among Patients With Schizophrenia Rebecca Schennach, Michael Obermeier, Sebastian Meyer et al. · Psychiatric Services	2012	104
15	Transcranial direct current stimulation as an additional treatment to selective serotonin reuptake inhibitors in adults with major depressive disorder in Germany (DepressionDC): a triple-blind, randomised, sham-controlled, multicentre trial Gerrit Burkhardt et al. · The Lancet	3 Jul 2023	96
16	Kidney disease as a determinant of cognitive decline and dementia Thorleif Etgen · Alzheimer s Research & Therapy Open access	16 Mar 2015	93
17	Clinical predictors of response and remission in inpatients with depressive syndromes Michael J Riedel, Hans‐Jürgen Möller, Michael Obermeier et al. · Journal of Affective Disorders	10 May 2011	81
18	Outcomes of 1014 naturalistically treated inpatients with major depressive episode Florian Seemüller, Michael J Riedel, Michael Obermeier et al. · European Neuropsychopharmacology	25 Jan 2010	78
19	Therapeutic Drug Monitoring of Tricyclic Antidepressants: How Does it Work under Clinical Conditions? Matthias J. Müller, Aleksandra Dragičević, M Fric et al. · Pharmacopsychiatry	May 2003	73
20	Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders Markus Jäger, Michael J Riedel, Thomas Messer et al. · European Archives of Psychiatry and Clinical Neuroscience Open access	10 Oct 2006	72
21	Psychophysiological effects of an iTBS modulated virtual reality challenge including participants with spider phobia Swantje Notzon, Saskia Deppermann, Andreas Jochen Fallgatter et al. · Biological Psychology	25 Oct 2015	70
22	Influence of 5-HTT variation, childhood trauma and self-efficacy on anxiety traits: a gene-environment-coping interaction study Miriam A. Schiele, Christiane Ziegler, Karoline Holitschke et al. · Journal of Neural Transmission	4 May 2016	69
23	The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants Pierre Baumann, Sven Ulrich, Gabriel Eckermann et al. · Dialogues in Clinical Neuroscience Open access	30 Sep 2005	67
24	Allelic variation in CRHR1 predisposes to panic disorder: evidence for biased fear processing Heike Weber et al. · Molecular Psychiatry Open access	Sep 2015	66
25	Attachment style and oxytocin receptor gene variation interact in influencing social anxiety Swantje Notzon, Katharina Domschke, Karoline Holitschke et al. · The World Journal of Biological Psychiatry	21 Oct 2015	66
26	Individual differences in human fear generalization—pattern identification and implications for anxiety disorders Yannik Stegmann, Miriam A. Schiele, Dirk Schümann et al. · Translational Psychiatry Open access	18 Nov 2019	65
27	Mismatch or allostatic load? Timing of life adversity differentially shapes gray matter volume and anxious temperament Manuel Kuhn, Robert Scharfenort, Dirk Schümann et al. · Social Cognitive and Affective Neuroscience Open access	13 Nov 2015	63
28	The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode Florian Seemüller, Michael J Riedel, Michael Obermeier et al. · The International Journal of Neuropsychopharmacology Open access	29 Jul 2008	63
29	Immunoassay screening in urine for synthetic cannabinoids – an evaluation of the diagnostic efficiency Florian S. Franz, Verena Angerer, Hanna Jechle et al. · Clinical Chemistry and Laboratory Medicine (CCLM)	2017	62
30	SPIDER OR NO SPIDER? NEURAL CORRELATES OF SUSTAINED AND PHASIC FEAR IN SPIDER PHOBIA Anna Luisa Münsterkötter, Swantje Notzon, Ronny Redlich et al. · Depression and Anxiety Open access	26 Jun 2015	62
31	Long-Term Observation of a Multicomponent Cognitive Intervention in Mild Cognitive Impairment Verena Caroline Buschert, Ina Giegling, Stefan Johannes Teipel et al. · The Journal of Clinical Psychiatry	15 Dec 2012	60
32	The Impact of Reboxetine and Mirtazapine on Driving Simulator Performance and Psychomotor Function in Depressed Patients Alexander Brunnauer, Gerd Laux, Irmgard David et al. · The Journal of Clinical Psychiatry	31 Dec 2008	60
33	Green fluorescent protein for detection of the probiotic microorganism Escherichia coli strain Nissle 1917 (EcN) in vivo Michael Schultz, Sonja Watzl, Tobias A. Oelschlaeger et al. · Journal of Microbiological Methods	21 Feb 2005	60
34	Electroconvulsive therapy induced gray matter increase is not necessarily correlated with clinical data in depressed patients Alexander Sartorius, Traute Demirakça, Andreas Böhringer et al. · Brain stimulation Open access	4 Dec 2018	59
35	State of Acute Agitation at Psychiatric Emergencies in Europe: The STAGE Study Luis San, Josef Marksteiner, Peter Zwanzger et al. · Clinical Practice and Epidemiology in Mental Health Open access	27 Oct 2016	59
36	Modulating Emotion Perception: Opposing Effects of Inhibitory and Excitatory Prefrontal Cortex Stimulation Swantje Notzon, Christian Steinberg, Peter Zwanzger et al. · Biological Psychiatry Cognitive Neuroscience and Neuroimaging	29 Dec 2017	58
37	Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale Rebecca Schennach-Wolff, Michael Obermeier, Florian Seemüller et al. · Acta Psychiatrica Scandinavica	4 Oct 2010	58
38	Subtypes of depression and their overlap in a naturalistic inpatient sample of major depressive disorder Richard Musil, Florian Seemüller, Sebastian Meyer et al. · International Journal of Methods in Psychiatric Research Open access	14 Jun 2017	55
39	Social Defeat Modulates T Helper Cell Percentages in Stress Susceptible and Resilient Mice Oliver Ambrée, Christina Ruland, Peter Zwanzger et al. · International Journal of Molecular Sciences Open access	17 Jul 2019	54
40	Predicting dementia in primary care patients with a cardiovascular health metric: a prospective population-based study Johannes Baltasar Hessler-Kaufmann, Karl‐Heinz Ander, Monika Brönner et al. · BMC Neurology Open access	26 Jul 2016	54
41	Combining machine learning algorithms for prediction of antidepressant treatment response Alexander Kautzky, Hans‐Juergen Möller, Markus Dold et al. · Acta Psychiatrica Scandinavica Open access	3 Nov 2020	53
42	Prefrontal transcranial direct current stimulation (tDCS) as treatment for major depression: study design and methodology of a multicenter triple blind randomized placebo controlled trial (DepressionDC) Frank Padberg, Ulrike Kumpf, Ulrich Mansmann et al. · European Archives of Psychiatry and Clinical Neuroscience	28 Feb 2017	53
43	CRHR1 promoter hypomethylation: An epigenetic readout of panic disorder? Christoph Schartner, Christiane Ziegler, Miriam A. Schiele et al. · European Neuropsychopharmacology	21 Feb 2017	53
44	Serotonin Transporter Gene Promoter Hypomethylation as a Predictor of Antidepressant Treatment Response in Major Depression: A Replication Study Miriam A. Schiele, Peter Zwanzger, Kathrin Schwarte et al. · The International Journal of Neuropsychopharmacology Open access	24 Oct 2020	52
45	Effects of electroconvulsive therapy on amygdala function in major depression – a longitudinal functional magnetic resonance imaging study Ronny Redlich, C. P. Burger, Katharina Dohm et al. · Psychological Medicine	11 Apr 2017	51
46	Evaluating Depressive Symptoms in Schizophrenia: A Psychometric Comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale Rebecca Schennach, Michael Obermeier, Florian Seemüller et al. · Psychopathology Open access	2012	51
47	Diabetes Type II: A Risk Factor for Depression–Parkinson–Alzheimer? Peter Franz Riederer, Jasmin Bartl, Gerd Laux et al. · Neurotoxicity Research	14 Jun 2010	51
48	Effects of physical activity on cognitive performance: a controlled clinical study in depressive patients Verena Caroline Buschert, D. Prochazka, Helga Bartl et al. · European Archives of Psychiatry and Clinical Neuroscience	27 Jun 2018	50
49	Differing brain structural correlates of familial and environmental risk for major depressive disorder revealed by a combined VBM/pattern recognition approach Nils Opel, Peter Zwanzger, Ronny Redlich et al. · Psychological Medicine	10 Sep 2015	49
50	Driving simulator performance and psychomotor functions of schizophrenic patients treated with antipsychotics Alexander Brunnauer, Gerd Laux, Sarah Zwick · European Archives of Psychiatry and Clinical Neuroscience	10 Jul 2009	48

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.